The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tempest Therapeutics Inc shares valued at $426,993 were purchased by Versant Venture Capital VI, L. on Aug 12 ’24. At $1.10 per share, Versant Venture Capital VI, L. acquired 387,999 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Versant Venture Capital VI, L. sold 400,000 shares, netting a total of over 540,040 in proceeds. Following the sale of shares at $1.35 each, the insider now holds 597,940 shares.
Before that, Versant Venture Capital VI, L. had sold 387,999 shares from its account. In a trade valued at $426,993, the 10% Owner traded Tempest Therapeutics Inc shares for $1.10 each. Upon closing the transaction, the insider’s holdings decreased to 387,999 shares, worth approximately $0.15 million.
As published in their initiating research note from Scotiabank on March 14, 2024, Tempest Therapeutics Inc [TPST] has been a Sector outperform and the price target has been revised to $13. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early February.
Analyzing TPST Stock Performance
During the last five days, there has been a drop of approximately -13.73%. Over the course of the year, Tempest Therapeutics Inc shares have dropped approximately -83.64%. Shares of the company reached a 52-week high of $6.0000 on 04/02/24 and a 52-week low of $0.6986 on 12/18/24. A 50-day SMA is recorded $0.9625, while a 200-day SMA reached $2.1289. Nevertheless, trading volume fell to 1.7 million shares from 2.91 million shares the previous day.
Support And Resistance Levels for Tempest Therapeutics Inc (TPST)
According to the 24-hour chart, there is a support level at 0.6967, which, if violated, would cause prices to drop to 0.6733. In the upper region, resistance lies at 0.7461. The next price resistance is at 0.7721. RSI (Relative Strength Index) is 28.15 on the 14-day chart, showing oversold technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.1050, which suggests the price will decrease in the coming days. Percent R is at 93.70%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
